- Derm Potpourri10:42Paper Chase 1 - HPV Vaccine4:56Prostate 2.018:19Paper Chase 2 - Trial of Pregabalin for Acute and Chronic Sciatica4:43HPV Vaccination9:56Ondansetron: Autobot or Decepticon?13:54Paper Chase 3 - Clinicians' Expectations of Benefits & Harms6:06Multiple SclerosisFree Chapter25:33Social Determinants of Health: Poverty17:29Preeclampsia16:53Paper Chase 4 - Testosterone Treatment & Coronary Plaque3:47Atrial Fibrillation10:50Things I Do, But Should I? Wound Repair9:25Paper Chase 5 - Costs of Misdiagnosed Cellulitis6:18The Summary14:24
Casey Parker synthesizes the recommendations from prostate cancer screening guidelines around the world and provides us with a patient centred approach. He recommends providing patients with paper handouts or web sites with clear and realistic data about screening. At a follow-up visit, the harms and possible benefits of screening can be discussed and a shared decision can be made. While the current best evidence does not support the use of PSA (or DREs) in prostate cancer screening, providers need to also factor in patients’ concerns and fears. He also reviews the PROTECT and PROMIS trials and how these findings should impact the evaluation of potential prostate cancers.